Cargando…

Characterization of adverse drug events identified by trigger in Brazilian pediatric inpatients()

OBJECTIVE: To describe the frequency and characteristics of adverse drug events in pediatric inpatients in a Brazilian tertiary teaching hospital. METHODS: A cross-sectional study was conducted by retrospective and manual chart review of 240 pediatric admissions to identify adverse drug events using...

Descripción completa

Detalles Bibliográficos
Autores principales: Silva, Lunara Teles, Modesto, Ana Carolina Figueiredo, Martins, Renato Rocha, Lopes, Flavio Marques
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9432297/
https://www.ncbi.nlm.nih.gov/pubmed/30817896
http://dx.doi.org/10.1016/j.jped.2018.12.009
_version_ 1784780297029550080
author Silva, Lunara Teles
Modesto, Ana Carolina Figueiredo
Martins, Renato Rocha
Lopes, Flavio Marques
author_facet Silva, Lunara Teles
Modesto, Ana Carolina Figueiredo
Martins, Renato Rocha
Lopes, Flavio Marques
author_sort Silva, Lunara Teles
collection PubMed
description OBJECTIVE: To describe the frequency and characteristics of adverse drug events in pediatric inpatients in a Brazilian tertiary teaching hospital. METHODS: A cross-sectional study was conducted by retrospective and manual chart review of 240 pediatric admissions to identify adverse drug events using 17 triggers. When triggers were detected in the chart, reviewers investigated the chart in depth to decide whether an event occurred. Consensus about the occurrence of the event was obtained in meeting with a healthcare team. Events were classified by harm category and drugs were classified according to the Anatomical Therapeutic Chemical Classification. Patients who had suffered were compared to those who had not experienced events using the chi-squared test and the Mann–Whitney U test. RESULTS: A total of 62 adverse events were found, and 18.8% of the patients had at least one event. Adverse events rates were 25.83 per 100 admissions, 20.27 per 1000 patient-days, 25.94 per 1000 drugs, and 2.12 per 1000 drug doses. All events found were classified as temporary harm, and cardiovascular drugs were most frequently related to events. Groups of patients with and without event were segregated (p < 0.05) by the length of stay, number of drugs, and drug doses. CONCLUSION: The use of triggers demonstrated its utility in a pediatric setting by identifying harm. Adverse events rates were found to be higher than those of previous studies, but the harm rate was lower than other studies. This study enables the measurement of adverse events in order to define strategies to mitigate or reduce harm.
format Online
Article
Text
id pubmed-9432297
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-94322972022-09-08 Characterization of adverse drug events identified by trigger in Brazilian pediatric inpatients() Silva, Lunara Teles Modesto, Ana Carolina Figueiredo Martins, Renato Rocha Lopes, Flavio Marques J Pediatr (Rio J) Original Article OBJECTIVE: To describe the frequency and characteristics of adverse drug events in pediatric inpatients in a Brazilian tertiary teaching hospital. METHODS: A cross-sectional study was conducted by retrospective and manual chart review of 240 pediatric admissions to identify adverse drug events using 17 triggers. When triggers were detected in the chart, reviewers investigated the chart in depth to decide whether an event occurred. Consensus about the occurrence of the event was obtained in meeting with a healthcare team. Events were classified by harm category and drugs were classified according to the Anatomical Therapeutic Chemical Classification. Patients who had suffered were compared to those who had not experienced events using the chi-squared test and the Mann–Whitney U test. RESULTS: A total of 62 adverse events were found, and 18.8% of the patients had at least one event. Adverse events rates were 25.83 per 100 admissions, 20.27 per 1000 patient-days, 25.94 per 1000 drugs, and 2.12 per 1000 drug doses. All events found were classified as temporary harm, and cardiovascular drugs were most frequently related to events. Groups of patients with and without event were segregated (p < 0.05) by the length of stay, number of drugs, and drug doses. CONCLUSION: The use of triggers demonstrated its utility in a pediatric setting by identifying harm. Adverse events rates were found to be higher than those of previous studies, but the harm rate was lower than other studies. This study enables the measurement of adverse events in order to define strategies to mitigate or reduce harm. Elsevier 2019-02-25 /pmc/articles/PMC9432297/ /pubmed/30817896 http://dx.doi.org/10.1016/j.jped.2018.12.009 Text en © 2019 Sociedade Brasileira de Pediatria. Published by Elsevier Editora Ltda. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Original Article
Silva, Lunara Teles
Modesto, Ana Carolina Figueiredo
Martins, Renato Rocha
Lopes, Flavio Marques
Characterization of adverse drug events identified by trigger in Brazilian pediatric inpatients()
title Characterization of adverse drug events identified by trigger in Brazilian pediatric inpatients()
title_full Characterization of adverse drug events identified by trigger in Brazilian pediatric inpatients()
title_fullStr Characterization of adverse drug events identified by trigger in Brazilian pediatric inpatients()
title_full_unstemmed Characterization of adverse drug events identified by trigger in Brazilian pediatric inpatients()
title_short Characterization of adverse drug events identified by trigger in Brazilian pediatric inpatients()
title_sort characterization of adverse drug events identified by trigger in brazilian pediatric inpatients()
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9432297/
https://www.ncbi.nlm.nih.gov/pubmed/30817896
http://dx.doi.org/10.1016/j.jped.2018.12.009
work_keys_str_mv AT silvalunarateles characterizationofadversedrugeventsidentifiedbytriggerinbrazilianpediatricinpatients
AT modestoanacarolinafigueiredo characterizationofadversedrugeventsidentifiedbytriggerinbrazilianpediatricinpatients
AT martinsrenatorocha characterizationofadversedrugeventsidentifiedbytriggerinbrazilianpediatricinpatients
AT lopesflaviomarques characterizationofadversedrugeventsidentifiedbytriggerinbrazilianpediatricinpatients